LO
LeonaBio, Inc.
LONA · NASDAQ
$7.56 -4.60% (-$0.36)
1M -1.56%
Market Cap $30.4M
P/E Ratio -
Div. Yield -
ROE 411.58%
Bulios Fair Price
$10.84
43.4% upside
Current Price
$7.56
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LONA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.90x
PEG N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 50.93%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 411.58%
ROA 248.63%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 7.01x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
38 /100
Moderate EPS volatility 20.41%
Profitable years 0
Beta 2.05x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LONA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark J. Litton
Employees
19
Headquarters
Bothell
Upcoming events
05 NOV
Earnings
Upcoming earnings report